Skip to contentApplication 103628
- Type
- BLA
- Sponsor
- BIOGEN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AVONEX | INTERFERON BETA-1A | VIAL | 30UG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 59627-002 | Avonex | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-002 | Avonex | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-002 | Avonex | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-002 | Avonex | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-002 | Avonex | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-003 | Avonex Pen | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-003 | Avonex Pen | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-003 | Avonex Pen | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-003 | Avonex Pen | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-003 | Avonex Pen | Interferon Beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-111 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-222 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |
| 59627-333 | AVONEX | interferon beta-1a | Biogen Inc. | BLA | Current |